U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Investigations - Other, Specify, CTCAE

MedGen UID:
1633672
•Concept ID:
C4684989
•
Finding

Recent clinical studies

Etiology

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel.
Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard JY; LUME-Lung 1 Study Group
Lung Cancer 2015 Nov;90(2):267-73. Epub 2015 Aug 12 doi: 10.1016/j.lungcan.2015.08.003. PMID: 26415992

Therapy

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel.
Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard JY; LUME-Lung 1 Study Group
Lung Cancer 2015 Nov;90(2):267-73. Epub 2015 Aug 12 doi: 10.1016/j.lungcan.2015.08.003. PMID: 26415992
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method.
Van Meter EM, Garrett-Mayer E, Bandyopadhyay D
Clin Trials 2012 Jun;9(3):303-13. Epub 2012 Apr 30 doi: 10.1177/1740774512443593. PMID: 22547420Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...